收费全文 | 13830篇 |
免费 | 909篇 |
国内免费 | 102篇 |
耳鼻咽喉 | 138篇 |
儿科学 | 496篇 |
妇产科学 | 347篇 |
基础医学 | 1569篇 |
口腔科学 | 312篇 |
临床医学 | 2029篇 |
内科学 | 2451篇 |
皮肤病学 | 164篇 |
神经病学 | 886篇 |
特种医学 | 519篇 |
外科学 | 1636篇 |
综合类 | 245篇 |
一般理论 | 11篇 |
预防医学 | 1410篇 |
眼科学 | 194篇 |
药学 | 1137篇 |
中国医学 | 29篇 |
肿瘤学 | 1268篇 |
2023年 | 62篇 |
2022年 | 91篇 |
2021年 | 258篇 |
2020年 | 150篇 |
2019年 | 241篇 |
2018年 | 300篇 |
2017年 | 205篇 |
2016年 | 238篇 |
2015年 | 274篇 |
2014年 | 407篇 |
2013年 | 593篇 |
2012年 | 860篇 |
2011年 | 896篇 |
2010年 | 573篇 |
2009年 | 431篇 |
2008年 | 828篇 |
2007年 | 933篇 |
2006年 | 925篇 |
2005年 | 839篇 |
2004年 | 789篇 |
2003年 | 781篇 |
2002年 | 785篇 |
2001年 | 360篇 |
2000年 | 336篇 |
1999年 | 268篇 |
1998年 | 179篇 |
1997年 | 154篇 |
1996年 | 126篇 |
1995年 | 121篇 |
1994年 | 102篇 |
1993年 | 82篇 |
1992年 | 157篇 |
1991年 | 110篇 |
1990年 | 136篇 |
1989年 | 125篇 |
1988年 | 120篇 |
1987年 | 108篇 |
1986年 | 97篇 |
1985年 | 88篇 |
1984年 | 67篇 |
1983年 | 73篇 |
1982年 | 48篇 |
1981年 | 57篇 |
1980年 | 47篇 |
1979年 | 54篇 |
1978年 | 45篇 |
1977年 | 43篇 |
1976年 | 32篇 |
1975年 | 29篇 |
1974年 | 50篇 |
Background
Persistent iatrogenic atrial septal defect (iASD) is a common but poorly characterized complication after cryoballoon (CB) pulmonary vein isolation (PVI) procedures. We therefore investigate its prevalence, evolution, risk factors, and clinical outcomes in a prospective longitudinal study.Methods
A total of 108 patients (41 women, mean age 57 ± 11.3) underwent CB PVI for AF. Serial transesophageal echocardiography (TEE) was performed 9 months and then annually until 6 years after the procedure to study the characteristics of persistent iASD.Results
Persistent iASD occurred in 33 (30.6%) patients 9 months after CB PVI. Spontaneous closure of iASD was found in 6 (22.2%) and 3 (15.8%) patients 2 and 3 years after the procedures, respectively. No spontaneous closure was observed on 4, 5, and 6-year TEE follow-up. The projected long-term persistence rate of iASD after CB PVI was therefore 20% (30.6% × 0.778 × 0.842). Using multivariate logistic regression, a higher number of cryoapplications (≥ 2 minutes) was the only independent predictor of persistent iASD 9 months after CB PVI (odds ratio [OR] 1.207; 95% confidence interval [CI], 1.033-1.411, P = 0.018). Two (1.9%) patients with significantly larger iASD size than the others (long diameter 12.6 ± 0.8 vs 3.7 ± 1.5 mm, P < 0.001; short diameter 10.9 ± 0.2 vs 3 ± 1.1 mm, P < 0.001) required percutaneous closure because of exertional dyspnea and right ventricular enlargement. Over 129.7 patient-years follow-up, during which iASD persisted, there was no occurrence of neurologic events.Conclusions
Approximately one fifth of patients undergoing CB PVI will have permanently persistent iASD. Patients with defect sizes of greater than 10 mm may need percutaneous closure due to significant left-to-right shunting. 相似文献Areas covered: Approximately 10–45% of patients undergoing head-and-neck cancers surgery develop SSIs. SSIs can lead to delayed wound healing, increased morbidity and mortality as well as costs. Consequently, SSIs need to be avoided where possible, as even the surgery itself impacts on patients’ subsequent activities and their quality of life, which is exacerbated by SSIs. Several risk factors for SSIs need to be considered to reduce future rates, and care is also needed in the selection and duration of antibiotic prophylaxis.
Expert commentary: Head and neck surgeons should give personalized care especially to patients at high risk of SSIs. Such patients include those who have had chemoradiotherapy and need reconstructive surgery, and patients from lower and middle-income countries and from poorer communities in high income countries, who often have high levels of co-morbidity because of resource constraints. 相似文献